AMINOGLUTETHIMIDE AND MEDROXYPROGESTERONE ACETATE IN THE TREATMENT OF PATIENTS WITH ADVANCED BREAST-CANCER - A PHASE-II STUDY OF THE ASSOCIATION-OF-MEDICAL-ONCOLOGY OF THE GERMAN-CANCER-SOCIETY (AIO)

被引：0
|
作者：
WANDER, HE [1 ]
NAGEL, GA [1 ]
BLOSSEY, HC [1 ]
KLEEBERG, U [1 ]
机构：
[1] HAEMATO ONKOL PRAXIS,D-2000 HAMBURG 50,FED REP GER
来源：
CANCER | 1986年 / 58卷 / 09期
关键词：
D O I：
10.1002/1097-0142(19861101)58:9<1985::AID-CNCR2820580905>3.0.CO;2-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1985 / 1989
页数：5
相关论文
共 50 条
  • [1] PHASE-II STUDY OF AMINOGLUTETHIMIDE AND MEDROXYPROGESTERONE ACETATE IN THE TREATMENT OF PATIENTS WITH ADVANCED BREAST-CANCER
    NAGEL, GA
    WANDER, HE
    BLOSSEY, HC
    CANCER RESEARCH, 1982, 42 (08) : 3442 - 3444
  • [2] 1,2,4-TRIGLYCIDYLURAZOL IN ADVANCED BREAST-CANCER - A TRIAL OF THE PHASE-II STUDY-GROUP OF THE ASSOCIATION-OF-MEDICAL-ONCOLOGY, GERMAN-CANCER-SOCIETY
    WANDER, HE
    BERDEL, WE
    BREMER, K
    PEUKERT, M
    QUEISSER, W
    CANCER TREATMENT REPORTS, 1987, 71 (01): : 93 - 94
  • [3] PHASE-II STUDIES OF 1, 2, 4-TRIGLYCIDYLURAZOL (TGU) IN SOLID TUMORS - PHASE-II STUDY-GROUP OF THE ASSOCIATION-OF-MEDICAL-ONCOLOGY OF THE GERMAN-CANCER-SOCIETY
    QUEISSER, W
    WANDER, HE
    POSSINGER, K
    FIEBIG, HH
    HEIM, ME
    PEUKERT, M
    ONKOLOGIE, 1986, 9 (05): : 283 - 284
  • [4] A PHASE-II STUDY OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER
    FALKSON, G
    FALKSON, HC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 11 (01) : 16 - 18
  • [5] ELLIPTINIUM ACETATE IN TREATMENT OF ADVANCED BREAST-CANCER - A PHASE-II STUDY
    BUZDAR, AU
    ESPARZA, L
    HORTOBAGYI, GN
    LICHTIGER, B
    HOLMES, FA
    HUG, V
    FRASCHINI, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 200 - 200
  • [6] 10TH ANNIVERSARY OF THE PHASE-II-STUDY-GROUP IN THE ASSOCIATION-FOR-MEDICAL-ONCOLOGY (AIO) OF THE GERMAN-CANCER-SOCIETY
    QUEISSER, W
    FIEBIG, HH
    BERDEL, WE
    ONKOLOGIE, 1994, 17 (03): : 210 - 210
  • [7] PHASE-II EVALUATION OF ORAL MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER - A NORTHERN CALIFORNIA ONCOLOGY GROUP-STUDY
    TAN, YO
    HENDRICKSON, C
    MCWHIRTER, K
    KOHLER, M
    HANNIGAN, JF
    CARLSON, RW
    CANCER TREATMENT REPORTS, 1987, 71 (10): : 969 - 970
  • [8] PHASE-II STUDY OF VINORELBINE BY ORAL ROUTE (IN A HARD GELATIN CAPSULE) FOR METASTATIC BREAST-CANCER PATIENTS - A TRIAL OF THE PHASE-I/II STUDY-GROUP OF THE ASSOCIATION-FOR-MEDICAL-ONCOLOGY OF THE GERMAN-CANCER-SOCIETY
    QUEISSER, W
    DOSS, A
    WANDER, HE
    BREMER, K
    BECHER, R
    RIECHE, K
    DELGADO, FM
    EDLER, L
    ONKOLOGIE, 1991, 14 (01): : 35 - &
  • [9] PHASE-II STUDY OF ELLIPTINIUM ACETATE SALVAGE TREATMENT OF ADVANCED BREAST-CANCER
    ROUESSE, J
    SPIELMANN, M
    TURPIN, F
    LECHEVALIER, T
    AZAB, M
    MONDESIR, JM
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (06) : 856 - 859
  • [10] MEDROXYPROGESTERONE ACETATE (MAP) AND AMINOGLUTETHIMIDE (AG) IN ADVANCED BREAST-CANCER - PRELIMINARY-REPORT OF A PHASE-II STUDY OF THE AIO (ARBEITSGEMEINSCHAFT-FUR-INTERNISTISCHE-ONKOLOGIE-DER-DEUTSCHEN-KREBSGESELLSCHAFT)
    WANDER, HE
    NAGEL, GA
    BLOSSEY, HC
    ONKOLOGIE, 1982, : 28 - &
12345